Finished
Refinement and Clinical Evaluation of the H-Man for Arm Rehabilitation After Stroke
NCT02188628 · Tan Tock Seng Hospital · Updated 12 Sept 2019
- What is being tested
- H-Man; Additional Conventional Therapy
- For
- Stroke
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 21 years to 85 years. About 44 people. The full rules are on the registry page.
- Where
- Singapore
- When
- Starts or started 1 July 2014, ends 31 March 2018. Registered 11 July 2014.
- Results
- None posted yet.
In the researchers' words
Locally, stroke remains the 4th cause of death, causing 8.4% of deaths annually in Singapore, and a leading cause of neurological disability worldwide. Nearly 40% of the stroke survivors will require specialized rehabilitation. In recent years, robot-aided therapy has been proposed as a means of complementing traditional therapy to alleviate the burden on therapists and on the healthcare system. For shoulder/elbow rehabilitation, dozens of robots have been proposed in the literature but only half a dozen have been commercialized and typically none are seen in local clinics, due to exceedingly high costs. A novel, compact, inexpensive robotic interface, named 'H-Man', was recently designed and developed at NTU for experiments in motor control neuroscience. The H-man can generate computer-controlled force fields to assist or resist a subject's motion and is potentially an optimal trade-off between clinical efficacy and robotic complexity. A first prototype of the H-Man is available at NTU.The primary aim of this proposed project is to assess to what extent the investigators H-Man is suitable for rehabilitation purposes using a feasibility pilot clinical trial design involving stroke survivors. The investigators believe that H-Man can be used for neuro-rehabilitation of stroke patients with hemiparetic weakness, motor incoordination and motor ataxia of the upper limbs.In close…
Sites
- Tan Tock Seng Rehabilitation CentreSingapore, Singapore
